baber/WOPTO huggingface dataset:
Patent JP-4046781-B2 (JP)
IPC: H01R9/26
Filed: 1995-10-31
Granted: 2008-02-13
Abstract: Distributor modules (1) are mounted side-by-side on a rail that has built-in power carrying tracks. A connecting distribution element (3) has a housing of insulation and embedded within this are metal pressings that are shaped to provide spring contact regions for externally inserted pins. Also built into the connection arrangement is a bridging element (12) that interconnects adjacent points and has a single contact with a base power rail. A number of such contact pairs can be built into a module.
Patent JP-2625129-B2 (JP)
IPC: C07K5/00
Filed: 1987-11-17
Granted: 1997-07-02
Abstract: Novel peptide analogues which exhibit inhibitory activity against aspartic proteinases of the general formula I:, <CHEM> a novel species of actinomycetous microorganism which produces said novel peptide analogues, a process for producing said novel analogues by culturing said species and a pharmaceutical composition containing said analogues.
Patent JP-4106111-B2 (JP)
IPC: G01N33/96
Filed: 1997-11-14
Granted: 2008-06-25
Abstract: The present invention relates to methods for the production of a stable troponin preparation and its use as a calibrator and/or control in immunoassays. The formulation is prepared from mammalian, preferably bovine, heart tissue which provides a calibrator/control composition which remains stable over a long period of time.
Patent JP-2942345-B2 (JP)
IPC: E01F15/14
Filed: 1990-11-20
Granted: 1999-08-30
Abstract: A vehicle crash barrier (10) for decelerating a vehicle that has left a roadway includes an elongated frame having a number of sections (14, 16, 18) including a front section (14) and at least one additional section (16, 18) arranged end to end along an axial direction. The frame is configured to collapse when axially struck on the front section (14) by a vehicle. A wire cable (122) extends generally parallel to the frame and has a forward end portion anchored independently of the frame and a rearward end portion. Friction brakes (140) are mounted to the front section for engaging the wire cable (122) to generate a retarding force to decelerate a vehicle as the brake (140) moves along the wire cable (122) during collapse of the frame following impact of the vehicle against the front section (14). Each section includes a pair of side panels (42), and axially adjacent side panels are connected by a flexible tension strap (46) by fasteners (44). The tension strap (46) operates to peel the fasteners (44) out of the side panels during axial collapse. The front section (14) is releasably secured to a ground anchor (80) by a directionally sensitive breakaway assembly. (100) .
Patent JP-2732921-B2 (JP)
IPC: C07C41/26
Filed: 1989-12-19
Granted: 1998-03-30
Abstract: The invention relates to a process for the preparation of polyglycerols (with more than 50% by weight of diglycerol) which are low in cyclic components, by reacting glycerol with chlorohydrins. In this reaction, glycerol is reacted with epichlorohydrin (instead of chlorohydrin) at temperatures from 20 DEG  to 120 DEG  C. and at certain mole ratios of glycerol to epichlorohydrin and in the presence of an acidic catalyst and the reaction mixture obtained, which has not been separated into its components, is reacted at a temperature from 50 DEG  C. to 120 DEG  C. according to the content of organically bound chlorine in the reaction mixture, with an alkaline-reacting, preferably aqueous solution. After the addition of water, the reaction mixture is desalinated via one or more cation and subsequent anion exchangers, dehydrated by distillation and the glycerol-polyglycerol mixture obtained is separated by fractional distillation into glycerol, diglycerol and higher polyglycerols.
Patent JP-H072762-B2 (JP)
IPC: C12R1/46
Filed: 1990-11-30
Abstract: In the process of wet milling of ensiled corn, the process is improved to produce a starch of higher value and less contaminated with protein by inoculating high moisture corn with certain nonpathogenic organisms at the time of ensiling.
Patent JP-2571506-B2 (JP)
IPC: A61B17/72
Filed: 1992-12-07
Granted: 1997-01-16
Abstract: An anchorage nail for the treatment of fractures of hollow bones is disclosed. It has a hollow shaft (10) with at least one transverse hole (28,30) disposed in a first end region (12), for receiving bone screws. In a second region (18), adjacent the driving end (24), a further transverse opening (26) is disposed. The nail is characterised in that the shaft is straight, with an other diameter smaller than the inner diameter of the cortical bone, and in that the transverse opening (26) in the second end region is elongated along the nail axis. An inner thread is formed in the second end region, extending into the transverse opening, for receiving a threaded pin (54,62) which may be brought into contact with the shaft of a bone screw (82) introduced through the transverse opening (26).
Patent JP-H0662392-B2 (JP)
IPC: A61K8/891
Filed: 1990-12-04
Abstract: A shampoo composition contains surfactant together with a cationic derivative of guar gum and an insoluble non-volatile silicone present as emulsified particles having average particle size below 2  mu m. The silicone is preferably incorporated as a pre-formed emulsion.
Patent JP-2721830-B2 (JP)
IPC: A61K47/48
Filed: 1987-11-27
Granted: 1998-03-04
Abstract: PCT No. PCT/GB87/00854 Sec. 371 Date Jul. 21, 1989 Sec. 102(e) Date Jul. 21, 1989 PCT Filed Nov. 27, 1987 PCT Pub. No. WO88/03810 PCT Pub. Date Jun. 2, 1988.Pharmaceutically active conjugates comprising a pharmaceutically active substance for treating a disorder of the body that involves a specified body tissue conjugated directly or indirectly with at least one fragment of an adhesive glycoprotein such as fibronectin, the said glycoprotein fragment(s) having improved binding specificity compared with the parent protein for the said body tissue.
Patent JP-2612145-B2 (JP)
IPC: C25B9/19
Filed: 1992-05-12
Granted: 1997-05-21
Abstract: An electrolytic cell for the labeling of proteins, peptides and other organic molecules employs a cathodic half cell and an anodic half cell, where a porous working electrode is located in one half cell and a counter electrode is located in the other of the half cell, the two half cells being divided by a separator. A reference electrode located in the half cell containing the working electrode, and placed outside the current path between the working electrode and the counter electrode confers precise control of the working electrode potential, which allows the maximum rate of labeling to be achieved while minimizing oxidative damage to the protein, peptide or organic molecules. Saturation of the working electrode with non-radioactive label coupled with a ratio of working electrode surface area to volume of half cell containing the working electrode between 0.001 to 10 cm<-><1> minimizes the problem of loss of activity of radiolabel due to adsorption on the working electrode. <IMAGE>
Patent JP-3149950-B2 (JP)
IPC: A61N1/30
Filed: 1991-10-25
Granted: 2001-03-26
Abstract: A dry-state iontophoretic drug delivery device (10, 20) is provided. The device has drug and electrolyte reservoirs (15, 16) which are initially in a non-hydrated condition. In one embodiment of the invention, a passageway (21, 22) is provided through the backing layer (13) and the electrode layer (11, 12) of both the donor electrode assembly (8) and the counter electrode assembly (9). Water or other liquid can be introduced through these passageways (21, 22) in order to hydrate the drug and electrolyte reservoirs (15, 16) and activate the device (10). In another embodiment of the device (20), the drug and electrolyte reservoirs (15, 16) are initially separated from their respective electrodes (11, 12). After the reservoirs (15, 16) are hydrated, they are placed in electrical contact with their respective electrodes (11, 12). By joining the reservoir (15, 16) to the electrode (11, 12) after hydration occurs, delamination problems are reduced.
Patent JP-3591844-B2 (JP)
IPC: C09J5/00
Filed: 1998-07-16
Granted: 2004-11-24
Abstract: A method fixes an optical fiber (15) in a connector (10) for an optical plug-in connection. The connector (10) includes a location body (11) having a bore hole (12) to receive the optical fiber (15). In accordance with the method, the optical fiber (15) is inserted into the bore hole (12) of the location body (11) and is fixed therein by bonding with an adhesive (19). Easy and stable bonding is achieved by using a solid chemically reactive adhesive (19) which is reacted when brought into a liquid state and which enables a temperature-resistant connection.
Patent JP-3122667-B2 (JP)
IPC: C10L1/16
Filed: 1991-04-09
Granted: 2001-01-09
Abstract: PCT No. PCT/EP91/00669 Sec. 371 Date Dec. 9, 1992 Sec. 102(e) Date Dec. 9, 1992 PCT Filed Apr. 8, 1991 PCT Pub. No. WO91/15562 PCT Pub. Date Oct. 17, 1991.Compositions comprising an ethylene- alpha -olefin copolymer, an ethylene-unsaturated ester copolymer, and a comb polymer improve the low temperature properties of fuel oils, especially high wax content oils.
Patent JP-3542357-B2 (JP)
IPC: A23L2/38
Filed: 1995-07-21
Granted: 2004-07-14
Abstract: The present invention relates to color and shelf stable beverage compositions comprising: a) from about 0.4% to about 1.5% tea extract wherein the level of caffeine is from about 0.85% to about 3.2%; and the tea solids content is from about 12% to about 60%; b) from about 10 ppm to about 40 ppm colorant; c) from about 300 ppm to about 1500 ppm erythorbic acid or ascorbic acid; d) from about 0.5% to about 8.0% citric acid; e) an effective amount of sweetener; and f) water; and wherein the tea extract contains unoxidized flavanols.
Patent JP-3471354-B2 (JP)
IPC: A61K8/00
Filed: 1992-10-13
Granted: 2003-12-02
Abstract: The invention relates to pharmaceutical compositions for topical application comprising a safe and effective amount of a pharmaceutical active, and from about 0.1% to about 10.0% of a high molecular weight cationic polymer. These compositions provide enhanced penetration of the pharmaceutical active.
Patent JP-3524919-B2 (JP)
IPC: C12N5/077
Filed: 1992-10-28
Granted: 2004-05-10
Abstract: A method is disclosed whereby cells having a desired function are seeded on and into biocompatible, biodegradable or non-degradable polymer scaffolding, previously implanted in a patient and infiltrated with blood vessels and connective tissue, to produce a functional organ equivalent. The resulting organoid is a chimera formed of parenchymal elements of the donated tissue and vascular and matrix elements of the host. The matrix should be a non-toxic, injectable porous template for vascular ingrowth. The pore size, usually between approximately 100 and 300 microns, should allow vascular and connective tissue ingrowth throughout approximately 10 to 90 % of the matrix, and the injection of cells such as hepatocytes without damage to the cells or patient. The introduced cells attach to the connective tissue and are fed by the blood vessels. Immediately prior to polymer implantation portacaval shunts can be created to provide trophic stimulatory factors to the implants to enhance replication and function.
Patent JP-H06102648-B2 (JP)
IPC: A61K31/22
Filed: 1991-05-15
Abstract: Novel mercaptoacylamino acid disulfide derivatives of formulae (I) and (II), wherein R<1> is lower alkyl, cyclolower alkyl, aryl or heteroaryl; R<2> is hydrogen; lower alkyl; cyclolower alkyl; lower alkyl substituted with hydroxy, lower alkoxy, mercapto, lower alkylthio, aryl, heteroaryl, aralkyloxy or aralkylthio; aryl; or heteroaryl; R<3> is -OR<5> or -NR<5>R<6>; R<4> and R<9> are independently -(CH2)qR<8>; R<5> and R<6> are independently selected from the group consisting of hydrogen, lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl and aryl lower alkyl, or R<5> and R<6> together with the nitrogen to which they are attached form a 5-7 membered ring; R<7> is phenyl substituted by 1-3 substituents selected from the group consisting of lower alkyl, lower alkoxy, cycloalkyl, halo, cyano and aminomethyl; R<8> is hydrogen, hydroxy, lower alkoxy, mercapto, lower alkylthio, aryl or heteroaryl; n is 1 or 2; p is 0 or 1; q is 0, 1 or 2; and t is 0 or 1; and the pharmaceutically acceptable salts thereof useful in the treatment of cardiovascular disorders and pain conditions and combinations of mercaptoacylamino acid disulfide derivatives and atrial natriuretic factors or angiotensin converting enzyme inhibitors useful for treating cardiovascular disorders are disclosed.
Patent JP-3583782-B2 (JP)
IPC: B01J20/32
Filed: 1994-09-24
Granted: 2004-11-04
Abstract: PCT No. PCT/EP94/03197 Sec. 371 Date Jul. 16, 1996 Sec. 102(e) Date Jul. 16, 1996 PCT Filed Sep. 24, 1994 PCT Pub. No. WO95/10355 PCT Pub. Date Apr. 20, 1995The invention relates to an improved method for gel permeation chromatography and to support materials for this method based on hydroxyl-containing base supports onto whose surfaces polymers are covalently bonded, wherein a) the base support comprises aliphatic hydroxyl groups, b) the covalently bonded polymers are bonded to the support via a terminal monomer unit, c) the linear polymers comprise monomer units of formula II, d) the polymers are crosslinked by ether bridges    <IMAGE>  II  in which R1, R2 and R3independently of one another are H or CH3, R4 is H or C1-C5-alkyl and n is an integer between 1 and 5.
Patent JP-3569921-B2 (JP)
IPC: C01B7/19
Filed: 1997-08-26
Granted: 2004-09-29
Abstract: A process for refining difluoromethane by removing hydrogen fluoride which is contained in difluoromethane and has been believed to be difficult to remove, which process comprises distilling a mixture of difluoromethane with hydrogen fluoride contained in difluoromethane is absorbed by sulfuric acid. <IMAGE>
Patent JP-4050794-B2 (JP)
IPC: C12M1/18
Filed: 1997-09-16
Granted: 2008-02-20
Abstract: By arranging reagents needed for a specific reaction in separate distinct chambers in a reagent cartridge and combining several such reagent cartridges in a cassette in a format that matches that of commonly used microtitre plates. e.g. the 96 well format or other standard formats. several drawbacks of well-known procedures can be eliminated.
Patent JP-4243347-B2 (JP)
IPC: B01J20/04
Filed: 1995-01-12
Granted: 2009-03-25
Abstract: Solid powdered reactive composition for the purification of a gas containing hydrogen chloride, the said reactive composition comprising more than 98% by weight of sodium bicarbonate and less than 2% by weight of sodium monocarbonate and exhibiting a particle size distribution defined by an average particle diameter of less than 0.050 mm and a particle size slope of less than 5.The reactive composition finds an application in the purification of flue gases from the incineration of household waste.
Patent JP-3696240-B2 (JP)
IPC: C22C5/02
Filed: 1995-01-30
Granted: 2005-09-14
Abstract: PCT No. PCT/EP95/00325 Sec. 371 Date Jul. 30, 1996 Sec. 102(e) Date Jul. 30, 1996 PCT Filed Jan. 30, 1995 PCT Pub. No. WO95/20696 PCT Pub. Date Aug. 3, 1995The invention relates to a spinneret of a very specific geometry which provides more strength compared with the commonly applied spinnerets, and to a spinneret made of a specific metal alloy which also provides a further high strength. In combination, a spinneret is resistant to spinning pressures up to 60.000 kPa if it is made of the specific geometry and made of the preferred metal alloy of gold, platinum, rhodium and palladium, which does not comprise contaminations and which material is very homogeneous and thus does not show an obvious second phase.
Patent JP-3715649-B2 (JP)
IPC: G02B6/00
Filed: 1996-01-30
Granted: 2005-11-09
Abstract: An optical tapered waveguide for use as a single device or in optical arrays is described. The optical waveguide contains at least one inclusive structure. The inclusion may possess an abrupt refractive index interface within the body of the tapered optical waveguide or it may consist of a graded refractive index region within the tapered optical waveguide. Light travels through the entire waveguide structure via total internal reflection. The inclusion provides for a more uniform light distribution output and increases the definition of the image plane by altering the direction of the light rays passing through the waveguide.
Patent JP-3703099-B2 (JP)
IPC: C07C401/00
Filed: 1994-05-06
Granted: 2005-10-05
Abstract: PCT No. PCT/GB94/00975 Sec. 371 Date Jan. 5, 1996 Sec. 102(e) Date Jan. 5, 1996 PCT Filed May 6, 1994 PCT Pub. No. WO94/26707 PCT Pub. Date Nov. 24, 1994The invention relates to novel 1 alpha -hydroxy vitamin D derivatives and their 20-epi analogues, comprising compounds of general formula (I)    <IMAGE>  (I)  where R1 and R2, which may be the same or different, each represents a hydrogen atom or an aliphatic, cycloaliphatic, araliphatic or aryl group or together with the nitrogen atom to which they are attached form a heterocyclic group; R3 represents a methyl group having  alpha - or  beta -configuration; X represents a valence bond or a C1-2alkylene group; Y represents -O-, -S-, -CH2- or -NR- where R is a hydrogen atom or an organic group; Z represents a valence bond or a C1-3alkylene group; and A= represents a cyclohexylidene moiety characteristic of the A-ring of a 1 alpha -hydroxylated vitamin D or analogue thereof, with the proviso that when -X-Y-Z- together represent an alkylene group containing up to 4 carbon atoms A= does not carry an exocyclic methylene group at the 10-position. Active compounds of the invention exhibit cell modulating activity while exhibiting a substantial lack of calcemic effect.\!
Patent JP-2697749-B2 (JP)
IPC: C10G7/06
Filed: 1994-05-16
Granted: 1998-01-14
Abstract: A process is disclosed for producing feedstocks for manufacturing high quality lube base oil utilizing unconverted oil, which is produced from a fuels hydrocracker unit. The first step of the process is the distillation of an atmospheric residue under vacuum in a first vacuum distillation unit to produce a vacuum gas oil. The vacuum gas oil is then hydrotreated in a first reaction unit to remove impurities and produce a treated vacuum gas oil. The treated vacuum gas oil is then subjected to hydrocracking in a second reaction unit to yield light hydrocarbons. The light hydrocarbons are then subjected to a series of fractional distillations to separate light oil products and an unconverted oil. All or a fraction of the unconverted oil is fed to a second vacuum distillation unit to produce feedstocks of high quality lube base oil and a remaining portion. The remaining portion and, optionally, a fraction of the unconverted oil is recycled from the second vacuum distillation unit to the second reaction unit.
Patent JP-3224544-B2 (JP)
IPC: C01F17/00
Filed: 1996-03-19
Granted: 2001-10-29
Abstract: PCT No. PCT/GB96/00575 Sec. 371 Date Jan. 2, 1998 Sec. 102(e) Date Jan. 2, 1998 PCT Filed Mar. 19, 1996 PCT Pub. No. WO96/30029 PCT Pub. Date Oct. 3, 1996Selected lanthanum carbonate hydrates may be administered into the gastrointestinal tract, to treat hyperphosphataemia in patients with renal failure.
Patent JP-3493030-B2 (JP)
IPC: H01L21/306
Filed: 1997-03-27
Granted: 2004-02-03
Abstract: A device for treating substrates includes a fluid container in which the substrates are contained during treatment. A nozzle system is connected to the sidewalls and/or bottom of the fluid container and includes a plurality of nozzles for introducing a fluid into the fluid container.
Patent JP-4156677-B2 (JP)
IPC: G01N33/58
Filed: 1999-04-16
Granted: 2008-09-24
Abstract: A method for sequential chemiluminescent detection of two differently labeled analytes on a single blot is described. In the method, a uniquely labeled DNA is detected with a horseradish peroxidase (HRP) substrate followed by the detection of another uniquely labeled DNA with a second different enzyme substrate which also inhibits the chemiluminescence generated by HRP. The sequential detection method described herein eliminates the need to strip and reprobe Southern, Northern and Western blots. Potential applications of this method include forensic DNA fingerprinting where more than one probe is used for probing a Southern blot, multiplex DNA sequencing of more than one template, detection of gene rearrangements, mutations and gene linkage.
Patent NO-335068-B2 (NO)
Inventor: HOLGERSEN KLAUS
IPC: A23K1/18
Filed: 2005-09-09
Abstract: The present invention relates to fish feed pellets containing up to 55% by weight of lipids and a method of making said pellets. The pellets contain lipid, the major part of which, being liquid at ambient temperature and comprising oils of marine, animal and/or vegetable origin, and a minor part of lipids having high melting points 99.9-95.5% by weight of the lipids being liquid at ambient temperature are present in the bulk of the pellets having a top coating constituting 0.1-4.5% by weight of the total lipid content and consisting of 100-17% by weigth of a) glyceride or b) free fatty acids or c) crude palm oil or mixtures of a), b) and c) and where the components a, b and c all have high melting points, and 0-83% by weight of lipids being liquid at ambient temperature. The top coating consitutes preferably 0.5-1.5% by weight of total lipid content. The method comprises forming porous pellets by extrusion of commonly used feed components and then exposing said pellets to the lipid being liquid at ambient temperature until the pellets are saturated to a degree of 99.9-95.5% by said liquid. The pellets are then cooled and treated with said active components a, b and/or c, which can be mixed with lipid being liquid at ambient temperature, until the pellets get a top coating constituting 0.1-4.5% by weight of the total lipid content of the pellets.
Patent PL-149269-B2 (PL)
IPC: B63H25/52
Filed: 1987-02-02
Abstract: Przedmiotem wynalazku jest sposób sterowania obiektu pływającego po zadanej trajektorii o
dowolnym kształcie z zastosowniem cyfrowej obróbki sygnałów.
Znane są sposoby prowadzenia obiektu pływającego po zadanej trajektorii, w których
maszyna cyfrowa oblicza kolejne wartości kursu i podaje je na konwencjonalnego autopilota
pracującego w układzie stabilizacji kursu zadanego.
Patent ES-2257976-B2 (ES)
Title: Lente oftalmologica terapeutica y profilactica para ojos pseudoafaquicos y/o en proceso de neurodegeneracion.
Inventor: SANCHEZ RAMOS CELIA
IPC: G02C7/10
Filed: 2006-01-10
Granted: 2007-03-16
Abstract: Lente oftalmológica terapéutica y profiláctica para ojos pseudo-afáquicos y/o en proceso de neurodegeneración. El objeto de la invención es una lente oftalmológica para ojos pseudo-afáquicos y/o con degeneración macular y retiniana, caracterizada por ser resultante de la aplicación de un filtro con pigmentación amarilla sobre una lente oftalmológica común, con el fin de protegerlos de las longitudes de onda corta del espectro visible (inferiores a 500 nm). Esta invención elude las dificultades y riesgos de las técnicas existentes para dotar de esta protección a los ojos operados de cataratas y mejorar la de aquéllos en procesos neurodegenerativos, lográndolo con la simple aplicación de una lente oftálmica. La invención consta de la combinación de una lente oftálmica común y un filtro de pigmentación amarilla que absorbe las longitudes de onda corta de 350/500 nm, ambos adecuados para su utilización en humanos.
Patent AU-2001249490-B2 (AU)
Title: Methods for enhancing plant health and protecting plants from stress
Inventor: RYU STEPHEN B
IPC: A01N25/02
Filed: 2001-03-27
Granted: 2005-06-23
Abstract: The present invention relates to a method of enhancing the health of plant or seed in order to protect a plant or a seed from a stress-related injury by treating a plant with a composition containing at least one lysophospholipid. The present invention further relates to a method of enhancing or accelerating the recovery of an injured plant by treating such injured plant with a composition containing at least one lysophospholipid. Finally, the present invention relates to a method of enhancing the germination of seeds and seedling vigour by treating seeds with a composition containing at least one lysophospholipid.